Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 25.81 -0.57 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.38 | 52 Week High | $5.17 | |||
| Open | $26.36 | 52 Week Low | $0.94 | |||
| Day High | $26.79 | P/E | N/A | |||
| Day Low | $25.76 | EPS | $0.00 | |||
| Volume | 2,631,290 | |||||
